美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
72205-176-30	72205-176	HUMAN PRESCRIPTION DRUG	Deferasorox	Deferasirox	GRANULE	ORAL	20220521	N/A	ANDA	ANDA214650	Novadoz Pharmaceuticals LLC	DEFERASIROX	90 mg/1	30 PACKET in 1 CARTON (72205-176-30) / 1 GRANULE in 1 PACKET (72205-176-61)
72205-076-30	72205-076	HUMAN PRESCRIPTION DRUG	Deferasorox	Deferasirox	GRANULE	ORAL	20210318	N/A	ANDA	ANDA214650	Novadoz Pharmaceuticals LLC	DEFERASIROX	360 mg/1	30 PACKET in 1 CARTON (72205-076-30) / 1 GRANULE in 1 PACKET (72205-076-61)
72205-075-30	72205-075	HUMAN PRESCRIPTION DRUG	Deferasorox	Deferasirox	GRANULE	ORAL	20210318	N/A	ANDA	ANDA214650	Novadoz Pharmaceuticals LLC	DEFERASIROX	180 mg/1	30 PACKET in 1 CARTON (72205-075-30) / 1 GRANULE in 1 PACKET (72205-075-61)
69539-199-30	69539-199	HUMAN PRESCRIPTION DRUG	Deferasorox	Deferasirox	GRANULE	ORAL	20210318	N/A	ANDA	ANDA214650	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	180 mg/1	30 PACKET in 1 CARTON (69539-199-30) / 1 GRANULE in 1 PACKET (69539-199-62)
69539-200-30	69539-200	HUMAN PRESCRIPTION DRUG	Deferasorox	Deferasirox	GRANULE	ORAL	20210318	N/A	ANDA	ANDA214650	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	360 mg/1	30 PACKET in 1 CARTON (69539-200-30) / 1 GRANULE in 1 PACKET (69539-200-62)
69539-303-30	69539-303	HUMAN PRESCRIPTION DRUG	Deferasorox	Deferasirox	GRANULE	ORAL	20220429	N/A	ANDA	ANDA214650	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	90 mg/1	30 PACKET in 1 CARTON (69539-303-30) / 1 GRANULE in 1 PACKET (69539-303-62)